COGT
Price
$26.71Alerts
Change
-$1.02 (-3.68%)
Updated
Nov 20 closing price
Capitalization
5.49B
115 days until earnings call
Intraday BUY SELL Signals
TRVI
Price
$13.35Alerts
Change
-$0.37 (-2.70%)
Updated
Nov 20 closing price
Capitalization
2.04B
122 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COGT vs TRVI

COGT vs TRVI Comparison Chart in %
View a ticker or compare two or three
VS
COGT vs. TRVI commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and TRVI is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for COGT with price predictions
Nov 20, 2026

COGT in downward trend: price may drop because broke its higher Bollinger Band on November 09, 2026

COGT broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 39 similar instances where the stock broke above the upper band. In 34 of the 39 cases the stock fell afterwards. This puts the odds of success at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COGT as a result. In 78 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.

The Moving Average Convergence Divergence Histogram (MACD) for COGT turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 40 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

COGT moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COGT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where COGT's RSI Indicator exited the oversold zone, 21 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +13.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where COGT advanced for three days, in 229 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

The Aroon Indicator entered an Uptrend today. In 151 of 192 cases where COGT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 34 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. COGT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.742) is normal, around the industry mean (3.596). P/E Ratio (-14.650) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (443.347).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for TRVI with price predictions
Nov 20, 2026

TRVI's RSI Oscillator ascending out of oversold territory

The RSI Indicator for TRVI moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 21 of the 22 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for TRVI crossed bullishly above the 50-day moving average on November 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +19.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRVI advanced for three days, in 240 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

The Aroon Indicator entered an Uptrend today. In 161 of 185 cases where TRVI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TRVI as a result. In 72 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for TRVI turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 40 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

TRVI moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for TRVI moved below the 200-day moving average on November 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRVI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

TRVI broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.350) is normal, around the industry mean (3.596). P/E Ratio (-40.943) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (443.347).

The Tickeron Profit vs. Risk Rating rating for this company is 23 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating steady price growth. TRVI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
COGT vs TRVI: Fundamental Ratings
COGT
TRVI
OUTLOOK RATING
1..100
5731
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
3423
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
7353
P/E GROWTH RATING
1..100
2628
SEASONALITY SCORE
1..100
4724

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRVI's Valuation (5) in the Pharmaceuticals Major industry is significantly better than the same rating for COGT (75) in the Miscellaneous industry. This means that TRVI’s stock grew significantly faster than COGT’s over the last 12 months.

TRVI's Profit vs Risk Rating (23) in the Pharmaceuticals Major industry is in the same range as COGT (34) in the Miscellaneous industry. This means that TRVI’s stock grew similarly to COGT’s over the last 12 months.

TRVI's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as COGT (99) in the Miscellaneous industry. This means that TRVI’s stock grew similarly to COGT’s over the last 12 months.

TRVI's Price Growth Rating (53) in the Pharmaceuticals Major industry is in the same range as COGT (73) in the Miscellaneous industry. This means that TRVI’s stock grew similarly to COGT’s over the last 12 months.

COGT's P/E Growth Rating (26) in the Miscellaneous industry is in the same range as TRVI (28) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to TRVI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTTRVI
RSI
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
87%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (COGT: $26.72 vs. TRVI: $13.35)
Brand notoriety: COGT and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 97% vs. TRVI: 123%
Market capitalization -- COGT: $5.49B vs. TRVI: $2.04B
COGT [@Biotechnology] is valued at $5.49B. TRVI’s [@Biotechnology] market capitalization is $2.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 1 FA rating(s) are green while TRVI’s FA Score has 3 green FA rating(s).

  • COGT’s FA Score: 1 green, 4 red.
  • TRVI’s FA Score: 3 green, 2 red.
According to our system of comparison, TRVI is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while TRVI’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 5 bearish.
  • TRVI’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, both COGT and TRVI are a bad buy in the short-term.

Price Growth

COGT (@Biotechnology) experienced а -6.46% price change this week, while TRVI (@Biotechnology) price change was -2.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.58%. For the same industry, the average monthly price growth was -18.26%, and the average quarterly price growth was -28.15%.

Reported Earning Dates

COGT is expected to report earnings on Mar 16, 2027.

TRVI is expected to report earnings on Mar 23, 2027.

Industries' Descriptions

@Biotechnology (-11.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with TSHA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then TSHA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-3.70%
TSHA - COGT
48%
Loosely correlated
-1.33%
ROIV - COGT
48%
Loosely correlated
-0.78%
PVLA - COGT
48%
Loosely correlated
-2.00%
ORIC - COGT
47%
Loosely correlated
-4.42%
ENGN - COGT
47%
Loosely correlated
-1.14%
More

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with COGT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
-2.70%
COGT - TRVI
49%
Loosely correlated
-3.70%
TSHA - TRVI
47%
Loosely correlated
-1.33%
SYRE - TRVI
45%
Loosely correlated
-4.26%
STTK - TRVI
45%
Loosely correlated
-1.98%
RLAY - TRVI
45%
Loosely correlated
+1.32%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UNG10.560.30
+2.92%
United States Natural Gas Fund LP (UNG)
MYHE23.34-0.18
-0.75%
State Street My2031 High Yield Corporate Bond ETF (MYHE)
EWUS41.83-1.19
-2.76%
iShares MSCI United Kingdom Small Cap ETF (EWUS)
RDVI25.89-0.92
-3.43%
FT Vest Rising Dividend Achievers Target Income ETF (RDVI)
ISRA56.55-2.02
-3.44%
VanEck Israel ETF (ISRA)